Surrogate gene therapy for muscular dystrophyChemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator EzutromidTherapies for rare diseases: therapeutic modalities, progress and challenges aheadPublisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
P50
description
British geneticist and anatomist; educator
@en
Brits klinische genetica
@nl
name
Kay Davies
@af
Kay Davies
@an
Kay Davies
@ast
Kay Davies
@bar
Kay Davies
@br
Kay Davies
@ca
Kay Davies
@co
Kay Davies
@cs
Kay Davies
@cy
Kay Davies
@da
type
label
Kay Davies
@af
Kay Davies
@an
Kay Davies
@ast
Kay Davies
@bar
Kay Davies
@br
Kay Davies
@ca
Kay Davies
@co
Kay Davies
@cs
Kay Davies
@cy
Kay Davies
@da
altLabel
Dame Kay Elizabeth Davies
@ca
Professor Dame Kay E Davies
@en
prefLabel
Kay Davies
@af
Kay Davies
@an
Kay Davies
@ast
Kay Davies
@bar
Kay Davies
@br
Kay Davies
@ca
Kay Davies
@co
Kay Davies
@cs
Kay Davies
@cy
Kay Davies
@da
P166
P1015
P214
P244
P1015
P1153
35414895000
P1368
P166
P1816
P19
P2070
kay-davies-11310